{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:39:56Z","timestamp":1791268796595,"version":"4.1.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"ImmusanT, Inc."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,10]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Cytokines have been extensively studied in coeliac disease, but cytokine release related to exposure to gluten and associated symptoms has only recently been described. Prominent, early elevations in serum interleukin (IL)-2 after gluten support a central role for T cell activation in the clinical reactions to gluten in coeliac disease. The aim of this study was to establish a quantitative hierarchy of serum cytokines and their relation to symptoms in patients with coeliac disease during gluten-mediated cytokine release reactions. Sera were analyzed from coeliac disease patients on a gluten free-diet (n = 25) and from a parallel cohort of healthy volunteers (n = 25) who underwent an unmasked gluten challenge. Sera were collected at baseline and 2, 4 and 6 h after consuming 10 g vital wheat gluten flour; 187 cytokines were assessed. Confirmatory analyses were performed by high-sensitivity electrochemiluminescence immunoassay. Cytokine elevations were correlated with symptoms. Cytokine release following gluten challenge in coeliac disease patients included significant elevations of IL-2, chemokine (C-C motif) ligand 20 (CCL20), IL-6, chemokine (C-X-C motif) ligand (CXCL)9, CXCL8, interferon (IFN)-\u03b3, IL-10, IL-22, IL-17A, tumour necrosis factor (TNF)-\u03b1, CCL2 and amphiregulin. IL-2 and IL-17A were earliest to rise. Peak levels of cytokines were generally at 4 h. IL-2 increased most (median 57-fold), then CCL20 (median 10-fold). Cytokine changes were strongly correlated with one another, and the most severely symptomatic patients had the highest elevations. Early elevations of IL-2, IL-17A, IL-22 and IFN-\u03b3 after gluten in patients with coeliac disease implicates rapidly activated T cells as their probable source. Cytokine release after gluten could aid in monitoring experimental treatments and support diagnosis.<\/jats:p>","DOI":"10.1111\/cei.13369","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T14:54:42Z","timestamp":1568127282000},"page":"68-78","source":"Crossref","is-referenced-by-count":70,"title":["Serum cytokines elevated during gluten-mediated cytokine release in coeliac disease"],"prefix":"10.1093","volume":"199","author":[{"given":"G","family":"Goel","sequence":"first","affiliation":[{"name":"ImmusanT, Inc., Cambridge, MA,, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J M","family":"Daveson","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Queensland, Herston, QLD, 4006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C E","family":"Hooi","sequence":"additional","affiliation":[{"name":"Sir Charles Gairdner Hospital, Perth, WA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7687-9654","authenticated-orcid":false,"given":"J A","family":"Tye-Din","sequence":"additional","affiliation":[{"name":"Immunology Division, The Walter and Eliza Hall Institute, Parkville, VIC, Australia"},{"name":"Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia"},{"name":"Department of Gastroenterology, The Royal Melbourne Hospital, Parkville, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Wang","sequence":"additional","affiliation":[{"name":"ImmusanT, Inc., Cambridge, MA,, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Szymczak","sequence":"additional","affiliation":[{"name":"ImmusanT, Inc., Cambridge, MA,, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L J","family":"Williams","sequence":"additional","affiliation":[{"name":"ImmusanT, Inc., Cambridge, MA,, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J L","family":"Dzuris","sequence":"additional","affiliation":[{"name":"ImmusanT, Inc., Cambridge, MA,, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K M","family":"Neff","sequence":"additional","affiliation":[{"name":"ImmusanT, Inc., Cambridge, MA,, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K E","family":"Truitt","sequence":"additional","affiliation":[{"name":"ImmusanT, Inc., Cambridge, MA,, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0764-7267","authenticated-orcid":false,"given":"R P","family":"Anderson","sequence":"additional","affiliation":[{"name":"ImmusanT, Inc., Cambridge, MA,, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,1]]},"reference":[{"key":"2022021407184565900_cei13369-bib-0001","first-page":"aaw7756","article-title":"Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease. Science","volume":"5","author":"Goel","year":"2019","journal-title":"Advances"},{"key":"2022021407184565900_cei13369-bib-0002","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/73200","article-title":"In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope","volume":"6","author":"Anderson","year":"2000","journal-title":"Nat Med"},{"key":"2022021407184565900_cei13369-bib-0003","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1073\/pnas.0608610104","article-title":"Tetramer visualization of gut-homing gluten-specific T cells in the peripheral blood of celiac disease patients","volume":"104","author":"Raki","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022021407184565900_cei13369-bib-0004","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/cei.12232","article-title":"Ex-vivo whole blood secretion of interferon (IFN)-gamma and IFN-gamma-inducible protein-10 measured by enzyme-linked immunosorbent assay are as sensitive as IFN-gamma enzyme-linked immunospot for the detection of gluten-reactive T cells in human leucocyte antigen (HLA)-DQ2.5(+) -associated coeliac disease","volume":"175","author":"Ontiveros","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"2022021407184565900_cei13369-bib-0005","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1084\/jem.191.4.603","article-title":"The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase","volume":"191","author":"Arentz-Hansen","year":"2000","journal-title":"J Exp Med"},{"key":"2022021407184565900_cei13369-bib-0006","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1046\/j.1365-2249.2000.01312.x","article-title":"B cell epitopes of gliadin","volume":"121","author":"Osman","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"2022021407184565900_cei13369-bib-0007","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1053\/j.gastro.2018.12.013","article-title":"Plasma cells are the most abundant gluten peptide MHC-expressing cells in inflamed intestinal tissues from patients with celiac disease","volume":"156","author":"Hoydahl","year":"2019","journal-title":"Gastroenterology"},{"key":"2022021407184565900_cei13369-bib-0008","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.febslet.2004.06.057","article-title":"Gliadin stimulates human monocytes to production of IL-8 and TNF-alpha through a mechanism involving NF-kappaB","volume":"571","author":"Jelinkova","year":"2004","journal-title":"FEBS Lett"},{"key":"2022021407184565900_cei13369-bib-0009","doi-asserted-by":"crossref","first-page":"20518","DOI":"10.3390\/ijms151120518","article-title":"Gliadin peptides as triggers of the proliferative and stress\/innate immune response of the celiac small intestinal mucosa","volume":"15","author":"Barone","year":"2014","journal-title":"Int J Mol Sci"},{"key":"2022021407184565900_cei13369-bib-0010","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/gut.37.6.766","article-title":"Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma","volume":"37","author":"Nilsen","year":"1995","journal-title":"Gut"},{"key":"2022021407184565900_cei13369-bib-0011","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/ajg.2008.138","article-title":"Transient cytokine-induced liver injury following administration of the humanized anti-CD3 antibody visilizumab (HuM291) in Crohn\u2019s disease","volume":"104","author":"Baumgart","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"2022021407184565900_cei13369-bib-0012","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa063842","article-title":"Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412","volume":"355","author":"Suntharalingam","year":"2006","journal-title":"N Engl J Med"},{"key":"2022021407184565900_cei13369-bib-0013","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1182\/blood.V94.7.2217.419k02_2217_2224","article-title":"Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8)","volume":"94","author":"Winkler","year":"1999","journal-title":"Blood"},{"key":"2022021407184565900_cei13369-bib-0014","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/apt.15435","article-title":"A randomized, placebo-controlled clinical trial of subcutaneous or intradermal Nexvax2, an investigational immunomodulatory peptide therapy for coeliac disease","volume":"50","author":"Truitt","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2022021407184565900_cei13369-bib-0015","doi-asserted-by":"crossref","DOI":"10.1111\/apt.15477","article-title":"Systemic interleukin-2 release after gluten is sensitive and specific for coeliac disease, and correlates with symptoms","author":"Tye-Din","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2022021407184565900_cei13369-bib-0016","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.immuni.2015.01.020","article-title":"Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair","volume":"42","author":"Zaiss","year":"2015","journal-title":"Immunity"},{"key":"2022021407184565900_cei13369-bib-0017","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/imr.12191","article-title":"IL-15: a central regulator of celiac disease immunopathology","volume":"260","author":"Abadie","year":"2014","journal-title":"Immunol Rev"},{"key":"2022021407184565900_cei13369-bib-0018","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fped.2019.00193","article-title":"Evolving therapy for celiac disease","volume":"7","author":"Yoosuf","year":"2019","journal-title":"Front Pediatr"},{"key":"2022021407184565900_cei13369-bib-0019","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1053\/j.gastro.2017.11.006","article-title":"HLA-DQ-gluten tetramer blood test accurately identifies patients with and without celiac disease in absence of gluten consumption","volume":"154","author":"Sarna","year":"2018","journal-title":"Gastroenterology"},{"key":"2022021407184565900_cei13369-bib-0020","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"2022021407184565900_cei13369-bib-0021","volume-title":"Common Terminology Criteria For Adverse Events (CTCAE), version 5.0","author":"National Cancer Institute (NCI)","year":"2019"},{"key":"2022021407184565900_cei13369-bib-0022","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1136\/gutjnl-2017-314853","article-title":"Outcome measures in coeliac disease trials: the Tampere recommendations","volume":"67","author":"Ludvigsson","year":"2018","journal-title":"Gut"},{"key":"2022021407184565900_cei13369-bib-0023","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cgh.2016.08.007","article-title":"Suspected nonceliac gluten sensitivity confirmed in few patients after gluten challenge in double-blind, placebo-controlled trials","volume":"15","author":"Molina-Infante","year":"2017","journal-title":". Clin Gastroenterol Hepatol"},{"key":"2022021407184565900_cei13369-bib-0024","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.3390\/nu5114614","article-title":"The clinical response to gluten challenge: a review of the literature","volume":"5","author":"Bruins","year":"2013","journal-title":"Nutrients"},{"key":"2022021407184565900_cei13369-bib-0025","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1021\/jf305122s","article-title":"Can an increase in celiac disease be attributed to an increase in the gluten content of wheat as a consequence of wheat breeding?","volume":"61","author":"Kasarda","year":"2013","journal-title":"J Agric Food Chem"},{"key":"2022021407184565900_cei13369-bib-0026","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00394-015-1062-3","article-title":"Intake and sources of gluten in 20- to 75-year-old Danish adults: a national dietary survey","volume":"56","author":"Hoppe","year":"2017","journal-title":"Eur J Nutr"},{"key":"2022021407184565900_cei13369-bib-0027","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S2468-1253(17)30110-3","article-title":"Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies","volume":"2","author":"Goel","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2022021407184565900_cei13369-bib-0028","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/00007890-198904000-00008","article-title":"Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients","volume":"47","author":"Abramowicz","year":"1989","journal-title":"Transplantation"},{"key":"2022021407184565900_cei13369-bib-0029","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00007890-199004000-00009","article-title":"In vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids","volume":"49","author":"Chatenoud","year":"1990","journal-title":"Transplantation"},{"key":"2022021407184565900_cei13369-bib-0030","doi-asserted-by":"crossref","first-page":"E980","DOI":"10.1073\/pnas.1620036114","article-title":"CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes","volume":"114","author":"Kooy-Winkelaar","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022021407184565900_cei13369-bib-0031","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1053\/j.gastro.2013.12.023","article-title":"Interleukin 15 and CD4(+) T cells cooperate to promote small intestinal enteropathy in response to dietary antigen","volume":"146","author":"Korneychuk","year":"2014","journal-title":"Gastroenterology"},{"key":"2022021407184565900_cei13369-bib-0032","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/mi.2010.36","article-title":"HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22","volume":"3","author":"Bodd","year":"2010","journal-title":"Mucosal Immunol"},{"key":"2022021407184565900_cei13369-bib-0033","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/ajg.2010.465","article-title":"Characterization of gliadin-specific Th17 cells from the mucosa of celiac disease patients","volume":"106","author":"Fernandez","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"2022021407184565900_cei13369-bib-0034","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1136\/gut.2007.129882","article-title":"Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease","volume":"57","author":"Fina","year":"2008","journal-title":"Gut"},{"key":"2022021407184565900_cei13369-bib-0035","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.4049\/jimmunol.0901919","article-title":"Characterization of IL-17A-producing cells in celiac disease mucosa","volume":"184","author":"Monteleone","year":"2010","journal-title":"J Immunol"},{"key":"2022021407184565900_cei13369-bib-0036","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1089\/gtmb.2018.0128","article-title":"Analysis of IL17A and IL21 expression in the small intestine of celiac disease patients and correlation with circulating thioredoxin level","volume":"22","author":"Faghih","year":"2018","journal-title":"Genet Test Mol Biomark"},{"key":"2022021407184565900_cei13369-bib-0037","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/00365521.2013.863966","article-title":"Expression pattern of T-helper 17 cell signaling pathway and mucosal inflammation in celiac disease","volume":"49","author":"Lahdenpera","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"2022021407184565900_cei13369-bib-0038","doi-asserted-by":"crossref","first-page":"e89068","DOI":"10.1371\/journal.pone.0089068","article-title":"Role of CXCR3\/CXCL10 axis in immune cell recruitment into the small intestine in celiac disease","volume":"9","author":"Bondar","year":"2014","journal-title":"PLoS ONE"},{"key":"2022021407184565900_cei13369-bib-0039","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1073\/pnas.0610115104","article-title":"The IL-15\/IL-15Ralpha on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells","volume":"104","author":"Sato","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022021407184565900_cei13369-bib-0040","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.coi.2017.08.012","article-title":"Novel mechanisms in immune tolerance to allergens during natural allergen exposure and allergen-specific immunotherapy","volume":"48","author":"van de Veen","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"2022021407184565900_cei13369-bib-0041","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13073-018-0604-8","article-title":"Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations","volume":"10","author":"Marquez","year":"2018","journal-title":"Genome Med"},{"key":"2022021407184565900_cei13369-bib-0042","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ng.102","article-title":"Newly identified genetic risk variants for celiac disease related to the immune response","volume":"40","author":"Hunt","year":"2008","journal-title":"Nat Genet"},{"key":"2022021407184565900_cei13369-bib-0043","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gut.33.10.1353","article-title":"Inhibition of binding of interferon-gamma to its receptor by salicylates used in inflammatory bowel disease","volume":"33","author":"Crotty","year":"1992","journal-title":"Gut"},{"key":"2022021407184565900_cei13369-bib-0044","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1158\/1078-0432.CCR-14-1678","article-title":"FDA approval: siltuximab for the treatment of patients with multicentric Castleman disease","volume":"21","author":"Deisseroth","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2022021407184565900_cei13369-bib-0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev-med-051914-021944","article-title":"Therapeutic targeting of IL-17 and IL-23 cytokines in immune-mediated diseases","volume":"67","author":"Fragoulis","year":"2016","journal-title":"Annu Rev Med"},{"key":"2022021407184565900_cei13369-bib-0046","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ebiom.2017.07.014","article-title":"A Natural CCR2 antagonist relieves tumor-associated macrophage-mediated immunosuppression to produce a therapeutic effect for liver cancer","volume":"22","author":"Yao","year":"2017","journal-title":"EBioMedicine"},{"key":"2022021407184565900_cei13369-bib-0047","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1038\/ncomms5741","article-title":"Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy","volume":"5","author":"Burton","year":"2014","journal-title":"Nat Commun"},{"key":"2022021407184565900_cei13369-bib-0048","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1084\/jem.20082901","article-title":"Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression","volume":"206","author":"Campbell","year":"2009","journal-title":"J Exp Med"},{"key":"2022021407184565900_cei13369-bib-0049","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/gut.2003.023150","article-title":"Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa","volume":"54","author":"Salvati","year":"2005","journal-title":"Gut"},{"key":"2022021407184565900_cei13369-bib-0050","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.4049\/jimmunol.177.6.4178","article-title":"Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells","volume":"177","author":"Gianfrani","year":"2006","journal-title":"J Immunol"},{"key":"2022021407184565900_cei13369-bib-0051","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1053\/j.gastro.2011.04.048","article-title":"Tolerance to ingested deamidated gliadin in mice is maintained by splenic, type 1 regulatory T cells","volume":"141","author":"Du Pre","year":"2011","journal-title":"Gastroenterology"},{"key":"2022021407184565900_cei13369-bib-0052","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1084\/jem.178.1.187","article-title":"Gliadin-specific, HLA-DQ(alpha 1*0501, beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients","volume":"178","author":"Lundin","year":"1993","journal-title":"J Exp Med"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.13369","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cei.13369","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cei.13369","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/199\/1\/68\/42507760\/cei13369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/199\/1\/68\/42507760\/cei13369.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T02:26:57Z","timestamp":1644805617000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/199\/1\/68\/6402744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,10,1]]},"published-print":{"date-parts":[[2019,12,10]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.13369","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2020,1]]},"published":{"date-parts":[[2019,10,1]]}}}